DXCM logo

DXCM
Dexcom Inc

10,048
Mkt Cap
$27.01B
Volume
11.02M
52W High
$93.25
52W Low
$54.11
PE Ratio
33.46
DXCM Fundamentals
Price
$70.02
Prev Close
$65.08
Open
$64.45
50D MA
$68.88
Beta
0.81
Avg. Volume
6.07M
EPS (Annual)
$2.09
P/B
9.81
Rev/Employee
$420,000.00
$26,304.04
Loading...
Loading...
Poll

Earnings Recap

• Reported GAAP EPS of $0.69 up 76.92% YoY • Reported revenue of $1.26B up 13.12% YoY • Dexcom reiterates fiscal year 2026 guidance, targeting Revenue of $5.16-$5.25 billion, Non-GAAP Gross Profit Margin of 63-64%, Operating Margin of 22-23%, and Adjusted EBITDA Margin of 30-31%.

Bullish

Dexcom achieved strong Q4 and full-year 2025 revenue growth, with significant increases in operating income. Product innovation and expanded market access through new CGM systems and regional coverage drove performance.

Bearish

Dexcom faced ongoing intellectual property litigation costs and business transition expenses, impacting non-GAAP measures. Total current assets decreased while current liabilities increased, indicating a shift in working capital.

Latest DXCM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.